Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
(1981) published in European Neurology administered DSIP as a slow intravenous infusion at 25 nmol/kg to six healthy volunteers in a double-blind crossover design
An in-house COA from "XYZ Labs Internal QC" is not independent verification
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)
Why is high pH bad
It is not intended for medical, veterinary, or therapeutic use
US$ 26.75
US$ 28.45
US$ 24.25
US$ 26.16
US$ 20.98
US$ 26.65
US$ 29.38
